October 2017 FDA Recall Bisoprolol Fumarate by Unichem Pharmaceuticals Usa Inc
D-0010-2018 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Unichem Pharmaceuticals Usa Inc on October 2, 2017 for the product Bisoprolol Fumarate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0010-2018

Reason for Recall
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.
Initiated
10-02-2017
Reported
10-25-2017
Quantity
96,876 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Unichem Pharmaceuticals Usa Inc
Product was distributed nationwide
Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa, 403 511, India, Marketed by: UNICHEM PHARMACEUTICALS, (USA), INC. Hasbrouck Heights, NJ 07604, NDC 29300-126-13.

Batch or Lot Expiration Information

Lot# : GBOL16001, GBOL16002, Exp 12/31/2017; GBOL16015, Exp 03/31/2018.